Taysha Gene Therapies, Inc. TSHA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $0-100% | $5.49M+171% | $0-100% | $1.99M+78.6% | $2.3M-32.5% | ||
| $33.81M+117% | $24.95M+62.8% | $25.75M+72.3% | $20.14M+33.6% | $15.57M-24.7% | ||
| $9.68M+18.6% | $8.83M+33.2% | $8.28M+4.8% | $8.6M+17.2% | $8.16M+15.2% | ||
| —— | $0— | $0-100% | —— | —— | ||
| $43.49M+83.3% | $33.79M+53.9% | $34.02M+22.9% | $28.74M+28.2% | $23.72M-14.5% | ||
| $43.49M+83.3% | $33.79M+53.9% | $34.02M+22.9% | $28.74M+28.2% | $23.72M-14.5% | ||
| -$43.49M-103% | -$28.3M-42.0% | -$34.02M-31.4% | -$26.75M-25.6% | -$21.42M+12.0% | ||
| $9K-52.6% | $12K-45.5% | $15K-37.5% | $17K-37.0% | $19K-34.5% | ||
| $2.59M+95.0% | $2.87M+68.8% | $3.17M+50.4% | $1.86M+29.1% | $1.33M-21.7% | ||
| $1.08M+1,096% | $449K-60.9% | $1.29M+245% | -$129K-135% | -$108K-140% | ||
| —— | —— | —— | —— | —— | ||
| -$42.41M-97.0% | -$27.85M-48.3% | -$32.73M-28.2% | -$26.88M-28.4% | -$21.53M+10.5% | ||
| -$0.12-50.0% | -$0.08-14.3% | -$0.09+10.0% | -$0.090.0% | -$0.08+20.0% | ||
| -$0.12-50.0% | -$0.08-14.3% | -$0.09+10.0% | -$0.090.0% | -$0.08+20.0% | ||
| 366.6M+36.1% | 319.7M+27.8% | 353.3M+31.9% | 298M+28.0% | 269.3M+16.5% | ||
| 366.6M+36.1% | 319.7M+27.8% | 353.3M+31.9% | 298M+28.0% | 269.3M+16.5% | ||
| $1.47M-3.9% | $1.64M+200% | $1.53M-9.9% | $1.46M+14.2% | $1.53M+45.3% | ||
| $0+100% | $736K+987% | $292K+489% | $273K+240% | -$102K-130% | ||
| -$31K-338% | -$30K+54.5% | -$37K+54.3% | -$237K-664% | $13K+360% | ||
| -$43.49M-103% | -$28.3M-42.0% | -$34.02M-31.4% | -$26.75M-25.6% | -$21.42M+12.0% | ||
| -$43.19M-104% | -$28M-42.7% | -$33.82M-32.1% | -$26.45M-26.0% | -$21.14M+11.9% | ||
| -$43.19M-104% | -$28M-42.7% | -$33.82M-32.1% | -$26.45M-26.0% | -$21.14M+11.9% | ||
| -$43.49M-103% | -$28.3M-42.0% | -$34.02M-31.4% | -$26.75M-25.6% | -$21.42M+12.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Taysha Gene Therapies, Inc.'s income statement data come from?
- Every line is extracted from Taysha Gene Therapies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.